Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is a leading provider of inpatient behavioral health care services. The company operates a network of facilities across the United States, offering a range of services to individuals with mental health and substance use disorders. Acadia competes with other healthcare providers in the behavioral health sector, striving to deliver quality care and achieve financial growth.
On February 26, 2026, John Ransom from Raymond James set a price target of $25 for ACHC. At that time, the stock was trading at $21.59, suggesting a potential upside of approximately 15.82%. This optimistic outlook aligns with Acadia's recent financial performance, as highlighted in their Q4 2025 earnings call. The company reported adjusted earnings of $0.07 per share, surpassing the Zacks Consensus Estimate of $0.03 per share, marking an earnings surprise of over 164%.
Despite the impressive earnings surprise, Acadia's profit declined by 89% compared to the previous year. However, the company achieved total revenues of $821.5 million for the quarter, a 6.1% increase year over year, exceeding the expected $799 million. This growth was driven by a 3.1% increase in patient days and a 2.5% rise in admissions, contributing to a 4.4% increase in same-facility revenues.
Looking forward, Acadia Healthcare anticipates revenues for 2026 to range between $3.37 billion and $3.45 billion, with an adjusted EBITDA projected between $575 million and $610 million. These projections reflect the company's strategic focus on expanding its services and optimizing operational efficiency. Despite challenges such as a decrease in the average length of stay and higher expenses, Acadia remains committed to achieving its financial targets.
Currently, ACHC's stock price is $21.48, reflecting a 3.09% increase with a change of $0.64. The stock has fluctuated between a low of $20.88 and a high of $22.27 during the trading day. Over the past year, ACHC has experienced a high of $42.85 and a low of $11.43. With a market capitalization of approximately $1.94 billion, Acadia continues to be a significant player in the behavioral health care industry.
